“Tina” is a street name for crystal methamphetamine — one of dozens of colloquial terms used to refer to the drug in different communities and contexts. The name is derived from the phonetic rendering of the word “crystal” and is particularly common in LGBTQ+ social and chemsex contexts, where methamphetamine use has been documented at significantly higher rates than in the general population.
Understanding what Tina is, why it is used, what it does to the body and brain, and what the path to recovery looks like is important — whether you are concerned about your own use, worried about someone you love, or simply trying to understand a term you have encountered.
What Is Tina?
Tina is crystal methamphetamine — a synthetic stimulant in the amphetamine class manufactured from precursor chemicals including pseudoephedrine. It typically appears as clear or bluish-white crystals or crystalline powder and is most commonly smoked, though it is also injected, snorted, or taken orally.
Crystal methamphetamine is a Schedule II controlled substance under the Controlled Substances Act — meaning it has a high potential for abuse and severe psychological or physical dependence. It is one of the most neurologically destructive substances encountered in addiction medicine.
Other street names for methamphetamine include crystal, crystal meth, ice, glass, shards, crank, speed, tweak, chalk, and go-fast. The specific name used often varies by region, community, and context. Tina is most commonly used in chemsex contexts — a term describing the use of substances to facilitate or enhance sexual activity — and in urban LGBTQ+ social environments, particularly in cities including Los Angeles, New York, and London.
Why Is Tina Used in Chemsex Contexts?
The prevalence of Tina in chemsex contexts is not coincidental. Methamphetamine produces specific effects — dramatically increased libido, reduced inhibitions, prolonged wakefulness, and heightened physical sensation — that have made it particularly prevalent in sexual contexts, especially among men who have sex with men (MSM).
Chemsex — also referred to as “party and play” (PnP) — typically involves the use of methamphetamine, GHB/GBL, and mephedrone in combination, often in social or sexual settings that extend over multiple days. The intersection of methamphetamine’s effects with sexual behavior creates a powerful conditioned association that significantly complicates recovery — the drug becomes neurologically linked to intimacy, pleasure, and social connection in ways that make abstinence feel like losing access to those experiences entirely.
This is clinically significant and worth naming directly: people using Tina in chemsex contexts often face a recovery challenge that is distinct from other methamphetamine use patterns, and treatment that does not address the sexual and relational dimensions of the use alongside the addiction itself is likely to be incomplete.
What Does Tina Do to the Brain?
Methamphetamine works by flooding the brain’s dopamine system with a surge of the neurotransmitter at levels far exceeding what any natural reward produces. It does this through a multi-pronged mechanism: triggering the active release of dopamine from storage vesicles, blocking dopamine reuptake transporters, and at higher doses inhibiting the enzyme responsible for dopamine breakdown.
The result is a dopamine surge estimated to be three to five times greater than cocaine — producing an intense, prolonged euphoria alongside dramatically increased energy, hyperfocus, and wakefulness.
With repeated use, the brain adapts to this artificial dopamine flood by reducing its own dopamine receptor density and dopamine production — a process called neuroadaptation. The brain’s natural reward system becomes progressively less responsive. Activities that used to feel pleasurable — food, sex, connection, achievement — feel flat, colorless, and motivationally empty without the drug. This is the neurological trap of methamphetamine dependence: the drug that initially amplified pleasure eventually becomes the only reliable source of it.
Chronic methamphetamine use causes measurable, documented damage to dopaminergic neurons in the striatum and prefrontal cortex. Neuroimaging studies show dopamine transporter losses of 20–30% in chronic meth users compared to non-users. Some of this damage recovers with prolonged abstinence — but recovery of dopamine function is slow, taking months to years, and is not always complete.
Short-Term Effects of Tina
The immediate effects of crystal methamphetamine include intense euphoria and a profound sense of well-being, dramatically increased energy and wakefulness — users can remain awake for 24–72 hours during a binge — hyperfocus and increased motivation, decreased appetite, elevated heart rate and blood pressure, increased body temperature, increased libido, reduced inhibitions, agitation and rapid thought, and jaw clenching and teeth grinding (bruxism).
The duration of Tina’s effects — 8–12 hours — is significantly longer than cocaine or crack, allowing for extended binges that severely disrupt sleep, nutrition, and normal physiological functioning.
Long-Term Health Consequences of Tina Use
Neurological damage. Chronic methamphetamine use damages the dopamine system in ways that impair natural reward, motivation, memory, and executive function. The cognitive deficits associated with chronic meth use — impaired working memory, reduced processing speed, poor decision-making — can persist for months or years after cessation and in some cases do not fully resolve.
Methamphetamine-associated psychosis. Methamphetamine psychosis — characterized by paranoid delusions, visual and auditory hallucinations, and agitated behavior — is one of the most clinically challenging presentations in emergency psychiatry. It can occur during acute intoxication and persist for weeks, months, or years after cessation in chronic users. In chemsex contexts, psychosis can emerge suddenly during multi-day use sessions, creating acute safety risks.
Cardiovascular disease. Methamphetamine causes significant cardiovascular damage including pulmonary hypertension, cardiomyopathy, coronary artery disease, and increased stroke and heart attack risk — even in young users without pre-existing cardiovascular conditions.
Meth mouth. Severe dental destruction is caused by the combination of dry mouth (reduced saliva production), bruxism, the acidic nature of meth, and poor oral hygiene during active use. Tooth decay progresses rapidly and extensively, often requiring full dental reconstruction.
Physical deterioration. Chronic Tina use produces visible, rapid physical decline — dramatic weight loss, skin picking caused by formication (the sensation of insects under the skin), severe acne, and accelerated aging effects that produce dramatic physical changes far beyond chronological age.
Infectious disease risk. Methamphetamine use — particularly in chemsex contexts involving injection or shared equipment — significantly increases the risk of HIV, hepatitis C, and other sexually transmitted infections. The disinhibiting effects of Tina on sexual behavior, combined with the physical risks of injection use, create a well-documented epidemiological link between Tina use and HIV transmission in MSM communities.
Signs of Tina Addiction
Methamphetamine addiction develops rapidly. Some users report compulsive use patterns emerging within weeks of first exposure. Signs that Tina use has become an addiction include inability to control or stop use despite repeated attempts, continued use despite obvious health, relationship, financial, or professional consequences, and prioritizing Tina use over basic needs including sleep, food, and hygiene.
Additional signs include spending increasing amounts of time obtaining, using, and recovering from use, multi-day binges followed by prolonged crashes, withdrawal symptoms — severe depression, fatigue, hypersomnia, and intense cravings — when not using, paranoia, hallucinations, or psychotic symptoms during or after use, significant relationship deterioration or social isolation, and loss of interest in activities, relationships, or goals that existed before use began. Our substance use disorder page provides more information on how dependence is assessed. Our what we treat page outlines the full range of conditions we address at Numa.
Tina and Co-Occurring Mental Health Conditions
Methamphetamine use and mental health conditions are deeply intertwined. Many people who use Tina — particularly in chemsex contexts — have underlying depression, anxiety, trauma, or shame-based experiences related to sexual identity that the drug initially appeared to relieve.
When methamphetamine is removed, these underlying conditions do not disappear — they resurface, often intensified by the neurological damage meth has caused to the brain’s mood regulation systems. At Numa Recovery Centers, co-occurring disorders are assessed at intake and treated concurrently throughout all levels of care — not as an afterthought, but as a clinical priority from day one.
Tina Withdrawal: What to Expect
Methamphetamine does not produce the dramatic physical withdrawal syndrome associated with opioids or alcohol — there are no seizures, no severe gastrointestinal symptoms. But meth withdrawal is genuinely debilitating in its own way, primarily through its psychological impact.
Tina withdrawal typically produces profound fatigue and hypersomnia — sleeping 12–18 hours per day for the first week — intense depression and anhedonia, severe drug cravings especially in the first one to two weeks, increased appetite and weight gain, cognitive fog and difficulty concentrating, anxiety and irritability, and in people with prior psychosis, potential re-emergence of psychotic symptoms.
The depression and anhedonia of meth withdrawal can be severe enough to require psychiatric support. If you or someone you know is experiencing suicidal ideation during meth withdrawal, please call or text 988 (Suicide and Crisis Lifeline) immediately.
Post-acute withdrawal syndrome (PAWS) — involving mood instability, sleep disruption, cognitive difficulties, and intermittent cravings — can persist for months after the acute phase resolves. This extended recovery timeline is why sustained clinical support and aftercare planning are essential components of meth treatment.
Treatment for Tina Addiction at Numa Recovery Centers
Recovery from Tina addiction is possible. It requires more than willpower — it requires clinical support that addresses the neurological damage, the psychological dimensions, and the specific context of the use.
Medical evaluation at admission assesses cardiovascular health, psychiatric status, and the presence of meth-associated psychosis or other acute complications before treatment begins.
Residential treatment is provided in a private, luxury therapeutic environment in Los Angeles, structured around daily clinical programming that addresses addiction from multiple dimensions simultaneously.
Evidence-based behavioral therapy including CBT and contingency management represents the most clinically supported interventions for stimulant use disorders and forms the therapeutic core of our residential program.
Dual diagnosis treatment for co-occurring depression, anxiety, trauma, and psychosis is integrated throughout all levels of care through our co-occurring disorders program — not offered as a separate track, but as a standard component of every client’s treatment.
Individual therapy addresses the specific relational, sexual, and identity-related dimensions of Tina use where relevant — recognizing that the context of use matters as much as the substance itself in designing effective treatment.
Aftercare planning is calibrated to the extended recovery timeline that methamphetamine addiction requires, beginning during residential treatment and continuing through discharge to ensure the support structure is in place before the client leaves.
To learn more about our treatment programs or therapies, visit those pages or speak with our admissions team directly. Verify your insurance online in minutes, or contact us with any questions. Call Numa Recovery Centers at (844) 748-4455 — our admissions team is available 24 hours a day.
Frequently Asked Questions
What is the Tina drug?
Tina is a street name for crystal methamphetamine — a synthetic stimulant that produces intense euphoria, dramatically increased energy, and heightened sexual arousal. The name is particularly common in LGBTQ+ and chemsex communities. It refers to the same substance as crystal meth, ice, glass, and other street names for methamphetamine.
Why is meth called Tina?
The name Tina is derived from the phonetic rendering of the word “crystal” — with “T” drawn from the middle syllable. The name became established in urban gay and chemsex communities and has spread more broadly as awareness of chemsex-related drug use has increased.
Is Tina the same as crystal meth?
Yes. Tina, crystal meth, ice, glass, and shards are all street names for crystal methamphetamine — the same Schedule II controlled substance with the same chemical composition, the same mechanism of action, and the same health risks regardless of what it is called.
How addictive is Tina?
Methamphetamine is among the most addictive substances known. Its dopamine surge is estimated to be three to five times greater than cocaine, and its effects last significantly longer — creating a powerful neurological conditioning that can establish compulsive use patterns within weeks of first exposure. The neurological damage to the dopamine system that chronic use produces means that natural rewards feel increasingly flat without the drug, deepening dependence over time.
What does Tina do to your body long-term?
Chronic Tina use causes dopamine system damage producing cognitive impairment and anhedonia, methamphetamine-associated psychosis, severe dental destruction, cardiovascular disease, dramatic physical deterioration, and significantly elevated risk of infectious disease including HIV and hepatitis C. Some neurological recovery occurs with prolonged abstinence, but full restoration to pre-use baseline is not always achieved.
How do I help someone addicted to Tina?
Express concern without ultimatums or judgment — people are more likely to engage with treatment when approached with care rather than confrontation. At Numa, our admissions team speaks with families and loved ones regularly and can provide guidance on how to approach the conversation. You can also contact us directly with any questions.
Medically reviewed by Dr. Ariella Morrow, MD, Medical Director, Numa Recovery Centers. Board Certified in Internal Medicine, MPH. Last reviewed: August 2026.
References: 1. Volkow ND, et al. (2001). Journal of Neuroscience, 21(23), 9414–9418. 2. Halkitis PN, Parsons JT, Stirratt MJ. (2001). Journal of Homosexuality, 41(2), 17–35. 3. Shoptaw SJ, et al. (2009). Cochrane Database of Systematic Reviews. 4. McKetin R, et al. (2006). Addiction, 101(10), 1473–1478.
